Xilio Therapeutics, Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Investor Rights Agreement, dated March 27, 2024, between the Registrant and Gilead Sciences, Inc
Investor Rights Agreements
Xilio Therapeutics, Inc.
Biotechnology
NY
2024
Common Stock Purchase Agreement, dated March 27, 2024, between the Registrant and Gilead Sciences, Inc
Stock Agreements
Xilio Therapeutics, Inc.
Biotechnology
NY
2024
Registration Rights Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto
Registration Rights Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2024
Securities Purchase Agreement, dated March 28, 2024, among Xilio Therapeutics, Inc. and the persons party thereto
Purchase Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2024
Form of Prefunded Warrant
Warrant Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2024
Amended and Restated Loan and Security Agreement, dated as of May 5, 2023, by and between Xilio Development, Inc. and Pacific Western Bank
Loan Agreements
Xilio Therapeutics, Inc.
Biotechnology
NC
2023
Loan and Security Agreement, dated as of November 21, 2019, as amended, by and between the Registrant and Pacific Western Bank
Loan Agreements
Xilio Therapeutics, Inc.
Biotechnology
NC
2022
2021 Employee Stock Purchase Plan
Stock Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2021
Form of Underwriting Agreement
Underwriting Agreements
Xilio Therapeutics, Inc.
Biotechnology
NY
2021
Loan and Security Agreement, dated as of November 21, 2019, as amended, by and between the Registrant and Pacific Western Bank
Loan Agreements
Xilio Therapeutics, Inc.
Biotechnology
NC
2021
Amended and Restated Registration Rights Agreement, dated as of February 23, 2021, by and among the Registrant and the other parties thereto
Registration Rights Agreements
Xilio Therapeutics, Inc.
Biotechnology
DE
2021
Specimen Stock Certificate evidencing the shares of common stock
Stock Agreements
Xilio Therapeutics, Inc.
Biotechnology
2021